摘要:
The present invention relates to a dental material comprising, relative to the total mass of the material: (a) 1 to 95 wt.-% of at least one polymerizable N,O-functionalized acrylic acid hydroxamide, (b) 0 to 70 wt.-% diluent monomer, (c) 0 to 70 wt.-%, cross-linker monomer, (d) 0.1 to 5.0 wt.-% polymerization initiator (e) 0 to 80 wt.-% filler, (f) 0 to 70 wt.-% solvent, and (g) 0 to 70 wt.-% adhesive monomer.
摘要:
Disclosed and claimed are liquid-crystalline cyclopropylalkyl or -alkenyl or heterocyclic compounds, process for their preparation, and their use in liquid-crystalline mixtures. The novel cyclopropylalkyl or -alkenyl or heterocyclic compounds are of the general formula ##STR1## In this formula A.sup.1, A.sup.2 and A.sup.3 are unsubstituted or substituted, aromatic or heteroaromatic molecular components such as 1,4-phenylene or pyrimidine-2,5-diyl which are linked via a single bond (in the case where k and m=0) or via functional groups M.sup.1 and M.sup.2, such as CO--O or CH.sub.2 --O; j, k, l, m and n are zero, 1 or 2. The radicals R.sup.2, R.sup.3 and R.sup.4 are H or alkyl/alkenyl, R.sup.1 is alkyl/alkenyl or one of the substitutents known from LC chemistry such as an .alpha.-haloalkanoic acid radical. At least one of the components A.sup.1, A.sup.2 and A.sup.3 can be heteroaromatic, and G is alkylene or alkenylene.
摘要:
The present invention relates to a dental material comprising, relative to the total mass of the material: (a) 1 to 95 wt.-% of at least one polymerizable N,O-functionalized acrylic acid hydroxamide, (b) 0 to 70 wt.-% diluent monomer, (c) 0 to 70 wt.-%, cross-linker monomer, (d) 0.1 to 5.0 wt.-% polymerization initiator (e) 0 to 80 wt.-% filler, (f) 0 to 70 wt.-% solvent, and (g) 0 to 70 wt.-% adhesive monomer.
摘要:
The present invention relates to the use of tetrahydro- and dihydroquinazolinones of formula I as protein kinase activators or inhibitors, a method for their manufacture, their use for the preparation of a medicament for the treatment of diseases, their use for the manufacture of a pharmaceutical composition and new tetrahydro- and dihydroquinazolinones.
摘要:
The present invention relates to the use of tetrahydro- and dihydroquinazolinones of formula I as protein kinase activators or inhibitors, a method for their manufacture, their use for the preparation of a medicament for the treatment of diseases, their use for the manufacture of a pharmaceutical composition and new tetrahydro- and dihydroquinazolinones.
摘要:
Bicyclic cyclopropane derivatives of the general Formula (I) in which n+m is 0 to 8; r is 1 to 4; R1 is absent or is a C1-C20 alkylene radical which can be interrupted by O or S, a cycloaliphatic C4-C12 radical, a bicyclic C4-C12 radical, a C6-C14 arylene or C7-C20 alkylenearylene radical; R2 is for r=1 a C1-C20 alkyl radical which can be interrupted by O or S, a cycloaliphatic C4-C12 radical, a bicyclic C4-C12 radical, a C6-C14 aryl or a C7-C20 alkylaryl radical; is for r>1 an r-times substituted aliphatic C1 to C20 radical which can be interrupted by O or S, a cycloaliphatic C4-C12 radical, an aromatic C6-C14 radical or aliphatic-aromatic C7-C20 radical; X is absent or is —CO—O—, —CO—NH— or —O—CO—NH—, and Y is CH2, O or S which is suitable in particular for the preparation of dental materials.
摘要:
The present invention relates to a process for preparing cyclopropylamines of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5 have specified meanings, by reacting(1) a carboxamide of the formula ##STR2## wherein R.sup.1, R.sup.2, and R.sup.3 have specified meanings, with(2) an olefin of the formula ##STR3## wherein R.sup.4, R.sup.5, and R.sup.6 have specified meanings, (3) alkylmagnesium halides or zinc alkyl compounds of the formulaR.sup.8 --X (VIII),wherein R.sup.8 has a specified meaning and X represents MgCl, MgBr, Mgl, ZnCl, ZnBr, Znl, or ZnR.sup.8, and(4) orthometallates of the formula (IX) ##STR4## wherein R.sup.9 has a specified meaning, Y represents Ti, Zr, or V.dbd.O, and Z represents chlorine, bromine, or C.sub.1 -C.sub.4 -alkyl,with the provisos that when is Y os Ti or Zr, then is 3 or 4 and r are zero or 1 and the sum q+r=4, and that when Y is V.dbd.O, then q represents 3 and r represents zero.
摘要:
The present invention relates to the use of tetrahydro- and dihydroquinazolinones of formula (I) as protein kinase activators or inhibitors, a method for their manufacture, their use for the preparation of a medicament for the treatment of diseases, their use for the manufacture of a pharmaceutical composition and new tetrahydro- and dihydroquinazolinones.